Richard B Lipton Selected Research

Richard B Lipton Research Topics

Disease

194	Migraine Disorders (Migraine) 10/2022 - 01/2002
100	Headache (Headaches) 02/2022 - 01/2002
51	Pain (Aches) 06/2022 - 01/2002
21	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2005
20	Cognitive Dysfunction 01/2022 - 02/2005
18	Nausea 01/2021 - 04/2010
14	Headache Disorders (Headache Syndromes) 10/2022 - 07/2003
13	Dementia (Dementias) 01/2022 - 02/2005
12	Epilepsy (Aura) 01/2022 - 04/2005
8	Obesity 08/2017 - 10/2006
6	Hyperalgesia 10/2021 - 06/2009
6	Inflammation (Inflammations) 11/2018 - 01/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2004
5	Prescription Drug Overuse 11/2020 - 10/2006
4	Dizziness (Lightheadedness) 06/2022 - 01/2011
4	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022 - 08/2005
4	Stroke (Strokes) 01/2022 - 02/2010
4	Dysgeusia (Parageusia) 01/2021 - 05/2018
4	Hypertension (High Blood Pressure) 01/2019 - 07/2002
4	Hyperacusis (Phonophobia) 05/2018 - 04/2010
4	Photophobia (Light Sensitivity) 05/2018 - 04/2010
4	Parkinson Disease (Parkinson's Disease) 10/2017 - 07/2006
4	Primary Headache Disorders 04/2017 - 05/2005
4	Fatigue 11/2014 - 02/2007
3	Sleepiness 06/2022 - 04/2011
3	Disease Progression 11/2021 - 02/2009
3	Tension-Type Headache (Tension Headache) 10/2017 - 06/2010
3	Insulin Resistance 01/2015 - 04/2006
2	Asthma (Bronchial Asthma) 01/2021 - 07/2002
2	Chronic Pain 10/2020 - 01/2009
2	Partial Epilepsies (Epilepsy, Partial) 11/2019 - 01/2018
2	Secondary Headache Disorders 01/2019 - 08/2013
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 11/2014
2	Weight Loss (Weight Reduction) 03/2017 - 04/2011
2	Myocardial Infarction 01/2017 - 02/2010

Drug/Important Bio-Agent (IBA)

35	Tryptamines (Triptans)IBA 06/2022 - 01/2002
21	Opioid Analgesics (Opioids)IBA 10/2021 - 05/2004
21	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 06/2010
20	Pharmaceutical PreparationsIBA 10/2022 - 09/2004
17	Pain-FreeIBA 08/2021 - 11/2002
15	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2022 - 04/2011
15	Calcitonin Gene-Related PeptideIBA 02/2022 - 05/2007
14	Biological ProductsIBA 01/2021 - 11/2007
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
12	erenumabIBA 01/2022 - 01/2018
11	Sumatriptan (Imigran)FDA LinkGeneric 01/2019 - 11/2002
10	Monoclonal AntibodiesIBA 02/2022 - 01/2018
9	ubrogepantIBA 04/2022 - 08/2016
9	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 07/2002
9	preemptIBA 12/2020 - 06/2010
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 09/2008
8	Topiramate (Topamax)FDA LinkGeneric 11/2020 - 02/2007
7	eptinezumabIBA 02/2022 - 11/2014
7	rimegepant sulfateIBA 10/2021 - 01/2019
7	fremanezumabIBA 04/2021 - 11/2015
6	ApolipoproteinsIBA 11/2020 - 01/2015
6	Analgesics (Analgesic Drugs)IBA 01/2019 - 07/2002
6	BarbituratesIBA 06/2015 - 11/2008
5	lasmiditanIBA 06/2022 - 12/2018
5	C-Reactive ProteinIBA 05/2022 - 01/2011
5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 04/2010
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2005
5	SolutionsIBA 01/2021 - 11/2010
5	TabletsIBA 01/2019 - 10/2012
5	barbituric acid (barbiturate)IBA 01/2019 - 02/2009
4	galcanezumabIBA 01/2022 - 09/2018
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 03/2006
4	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2017
4	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2020 - 01/2018
4	PowdersIBA 01/2019 - 11/2010
3	Polymethyl Methacrylate (Sol)IBA 01/2022 - 01/2020
3	atogepantIBA 01/2022 - 01/2021
3	Amyloid beta-PeptidesIBA 11/2021 - 05/2005
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
3	Celecoxib (Celebrex)FDA Link 01/2021 - 01/2020
3	Apolipoproteins E (ApoE)IBA 11/2020 - 01/2019
3	Naproxen (Naprosyn)FDA LinkGeneric 04/2019 - 07/2010
3	Nonprescription Drugs (Patent Medicines)IBA 10/2018 - 01/2005
3	Ibuprofen (Motrin)FDA LinkGeneric 10/2017 - 03/2006
3	Diclofenac (SR 38)FDA LinkGeneric 05/2017 - 02/2004
2	CytokinesIBA 05/2022 - 01/2018
2	Apolipoprotein E4IBA 01/2022 - 05/2016
2	CholesterolIBA 10/2020 - 01/2019
2	LipidsIBA 09/2019 - 01/2019
2	Nasal SpraysIBA 01/2019 - 05/2018
2	DFN-02IBA 01/2019 - 05/2018
2	Hormones (Hormone)IBA 08/2017 - 07/2016
2	Ergot AlkaloidsIBA 07/2017 - 01/2017

Therapy/Procedure

60	Therapeutics 10/2022 - 01/2002
6	Ambulatory Care (Outpatient Care) 06/2021 - 01/2012
6	Autogenic Training 03/2021 - 12/2012
5	Contraindications 06/2022 - 09/2013
4	Aftercare (After-Treatment) 02/2022 - 04/2010
4	Drug Therapy (Chemotherapy) 03/2021 - 05/2009
3	Transcranial Magnetic Stimulation 01/2018 - 04/2010
3	Injections 03/2015 - 06/2010
2	Activities of Daily Living (ADL) 01/2022 - 10/2018
2	Vagus Nerve Stimulation 01/2022 - 08/2016
2	Psychology Biofeedback (Biofeedback) 10/2021 - 02/2011